AZN vs. JNJ: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AZN and JNJ, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With AZN at 432.07 billion USD and JNJ at 368.56 billion USD, their market capitalizations sit in the same ballpark.
JNJ carries a higher beta at 0.41, indicating it’s more sensitive to market moves, while AZN remains steadier at 0.18.
AZN trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while JNJ remains a standard domestic listing.
| Symbol | AZN | JNJ |
|---|---|---|
| Company Name | AstraZeneca PLC | Johnson & Johnson |
| Country | GB | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| CEO | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. | Mr. Joaquin Duato |
| Price | 69.68 USD | 153.18 USD |
| Market Cap | 432.07 billion USD | 368.56 billion USD |
| Beta | 0.18 | 0.41 |
| Exchange | NASDAQ | NYSE |
| IPO Date | May 12, 1993 | January 2, 1943 |
| ADR | Yes | No |
Performance Comparison
This chart compares the performance of AZN and JNJ over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AZN and JNJ, please refer to the table below.
| Symbol | AZN | JNJ |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 27.80 | 16.90 |
| Forward PEG Ratio (TTM) | 2.50 | 2.67 |
| Price-to-Sales Ratio (P/S, TTM) | 3.93 | 4.13 |
| Price-to-Book Ratio (P/B, TTM) | 5.26 | 4.72 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 22.33 | 19.84 |
| EV-to-EBITDA (TTM) | 13.68 | 11.02 |
| EV-to-Sales (TTM) | 4.41 | 4.28 |
| EV-to-Free Cash Flow (TTM) | 25.07 | 20.58 |
Dividend Comparison
JNJ stands out with a 2.43% dividend yield—around 75% above AZN’s 1.39%—highlighting its emphasis on generous payouts.
| Symbol | AZN | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 1.39% | 2.43% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AZN and JNJ, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- AZN’s current ratio of 0.90 signals a possible liquidity squeeze, while JNJ at 1.26 comfortably covers its short-term obligations.
- AZN’s quick ratio of 0.70 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas JNJ at 1.03 maintains a comfortable buffer of liquid assets.
| Symbol | AZN | JNJ |
|---|---|---|
| Current Ratio (TTM) | 0.90 | 1.26 |
| Quick Ratio (TTM) | 0.70 | 1.03 |
| Debt-to-Equity Ratio (TTM) | 0.77 | 0.67 |
| Debt-to-Assets Ratio (TTM) | 0.30 | 0.27 |
| Interest Coverage Ratio (TTM) | 7.95 | 27.46 |